Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapy. (Record no. 9235816)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02230 a2200577 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250513123542.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 199709s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0732-183X |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1200/JCO.1997.15.8.2966 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Lofters, W S |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 19970908 |
245 00 - TITLE STATEMENT | |
Title | Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapy. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
Date of publication, distribution, etc. | Aug 1997 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 2966-73 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Administration, Oral |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antiemetics |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dexamethasone |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Double-Blind Method |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Therapy, Combination |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Indoles |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Injections, Intravenous |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Nausea |
General subdivision | chemically induced |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ondansetron |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Premedication |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Quality of Life |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Quinolizines |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vomiting |
General subdivision | chemically induced |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pater, J L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zee, B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Dempsey, E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Walde, D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Moquin, J P |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wilson, K |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hoskins, P |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Guevin, R M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Verma, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Navari, R |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Krook, J E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hainsworth, J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Palmer, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chin, C |
773 0# - HOST ITEM ENTRY | |
Title | Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
Related parts | vol. 15 |
-- | no. 8 |
-- | p. 2966-73 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1200/JCO.1997.15.8.2966">https://doi.org/10.1200/JCO.1997.15.8.2966</a> |
Public note | Available from publisher's website |
No items available.